CT Lung Analysis
Cookies: We are sorry we can’t show you this video – as matter of your Cookies preferences. Accept here the Targeting Cookies to watch the video content.
CT Lung Analysis* aids in measuring and characterizing lung nodules. The interface and automated tools help to efficiently determine growth patterns and compose comparative reviews.
Key Benefits
- Automated segmentation of lung and airways with expert presets for visualization
- Single-click lung nodule segmentation tools to include solid nodules and ground glass opacity (GGO) nodules
- Quantification of lung nodules with nodule growth and doubling times in comparison studies
- Streamlined workflow transfers lung nodule findings to your site’s existing PowerScribe® 360 deployment
- Additional software offerings (CT Lung Density Analysis, Lung CAD, Visia CT Lung CAD) for Lung Screening Initiatives
Lung CAD
Lung CAD is a computer-aided detection (CAD) system for chest multi-slice CT exams. Lung CAD automatically detects potentially actionable lung nodules from 4 mm to 30 mm in size. Lung nodules detected in Lung CAD can be shown within CT Lung Analysis.
* Vitrea Advanced Visualization is owned and manufactured by Canon Medical Informatics, Inc.
Lung CAD is a separately licensed feature within the CT Lung Analysis application
Lung CAD is not available in the U.S.
Key Benefits
- Improves technologist’s and radiologist’s workflow by automatically detecting pulmonary nodules in CT images
- Clinically validated CAD performance designed to help improve reader accuracy
* Vitrea Advanced Visualization is owned and manufactured by Canon Medical Informatics, Inc.
Lung CAD is a separately licensed feature within the CT Lung Analysis application
Lung CAD is not available in the U.S.
Your partner to fight against lung cancer
Lung cancer is one of the most frequent causes of cancer and the leading cause of cancer death globally1. However, when the disease is detected at an early stage, the chances of survival increase dramatically2.
Canon Medical offers a unique set of lung cancer screening solutions. These include a suite of innovative technologies to enhance your clinical confidence everywhere, delivering high-quality imaging at low dose, streamlining workflows, and offering comprehensive diagnosis throughout the entire cycle of care.
1. Globocan 2020
2. Oudkerk M. et al | Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology (2021)
Canon Medical offers a unique set of lung cancer screening solutions. These include a suite of innovative technologies to enhance your clinical confidence everywhere, delivering high-quality imaging at low dose, streamlining workflows, and offering comprehensive diagnosis throughout the entire cycle of care.
1. Globocan 2020
2. Oudkerk M. et al | Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives | Nature Reviews Clinical Oncology (2021)
Due to medical device regulatory reasons, not all products/service displayed on this Canon Medical Systems Regional Headquaters' webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Systems representative for further details.
